ChemBK
  • Home
  • Product Category


Suvorexant Intermediate V

5-Chloro-2-((R)-5-Methyl-[1,4]diazepan-1-yl)benzooxazole hydrochloride

CAS: 1266664-66-7

Molecular Formula: C13H17Cl2N3O

  1. Home
  2. Product Category
  3. Suvorexant Intermediate V

Suvorexant Intermediate V - Names and Identifiers

Name 5-Chloro-2-((R)-5-Methyl-[1,4]diazepan-1-yl)benzooxazole hydrochloride
Synonyms EOS-61936
Suvorexant internate 3
Suvorexant Intermediate V
R-5-chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole HCl
-5-chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole hydrochloride
(R)-5-Chloro-2-(5-methyl-[1,4]diazepan-1-yl)-benzoxazole hydrochloride
5-Chloro-2-((R)-5-Methyl-[1,4]diazepan-1-yl)benzooxazole hydrochloride
CAS 1266664-66-7
EINECS 690-742-7

Suvorexant Intermediate V - Physico-chemical Properties

Molecular FormulaC13H17Cl2N3O
Molar Mass302.19958
Density1.369 at 20.5℃
Vapor Presure0-25Pa at 20-70℃
AppearanceSolid:particulate/powder
Suvorexant Intermediate V
Supplier List
Shanghai Macklin Biochemical Co., Ltd
Spot supply
Product Name: (R)-5-Chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole hydrochloride Visit Supplier Webpage Request for quotation
CAS: 1266664-66-7
Tel: +86-18821248368
Email: Int06@meryer.com
Mobile: +86-18821248368
QQ: 495145328 Click to send a QQ message
WhatsApp: +86-18821248368
Shanghai Macklin Biochemical Co., Ltd
Spot supply
Product Name: (R)-5-Chloro-2-(5-methyl-1,4-diazepan-1-yl)benzo[d]oxazole hydrochloride Visit Supplier Webpage Request for quotation
CAS: 1266664-66-7
Tel: +86-18821248368
Email: Int06@meryer.com
Mobile: +86-18821248368
QQ: 495145328 Click to send a QQ message
WhatsApp: +86-18821248368
View History
Suvorexant Intermediate V
N-(5-硝基-1H-吲唑-3-基)苯甲酰胺
3-Benzoyltrifluoromethanesulfonanilide
2-(4-甲基哌嗪-1-基)苯甲酸
3-叔丁基-4-羟基苯甲醚
Vanillactic Acid
3H-Pyrazolo[3,4-c]pyridin-3-one, 1,2,4,5,6,7-hexahydro-1-methyl-
8-氯-7-碘-2-甲基咪唑并[1,2-a]吡啶
N-{2-[(2,5-dimethoxyanilino)carbonyl]-4-iodophenyl}-2-furamide
2-氨基-3-O-氯苯甲酰基-5-乙基噻吩
  • Home
  • Product Category

© 2015, 2023 ChemBK.com All Rights Reserved | Build: 20230617001